NCT03904862 2025-10-30Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have SurgeryPediatric Brain Tumor ConsortiumPhase 1/2 Terminated21 enrolled